Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study (Q38383571)

From Wikidata
Jump to navigation Jump to search
scientific article published on 09 December 2016
edit
Language Label Description Also known as
English
Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study
scientific article published on 09 December 2016

    Statements

    Long-term Immunogenicity of Elosulfase Alfa in the Treatment of Morquio A Syndrome: Results From MOR-005, a Phase III Extension Study (English)
    Brian Long
    Troy Tompkins
    Celeste Decker
    Lynne Jesaitis
    Shahid Khan
    Peter Slasor
    Paul Harmatz
    Charles A O'Neill
    Becky Schweighardt
    9 December 2016
    118-129.e3

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit